Badger Meter CEO Kenneth Bockhorst buys $258,573 in stock

Badger Meter CEO Kenneth Bockhorst bought 2,200 shares at $117.53 for a total of $258,573, lifting his direct stake to 51,676 shares. The purchase comes after a weak fiscal Q1 2026 report, where EPS missed consensus by 23 cents ($0.93 vs. $1.20) and revenue missed by $28.0 million ($202.3 million vs. $230.3 million), triggering target cuts from Stifel to $140 and RBC to $169. The stock is near its 52-week low of $112.09 and has fallen nearly 30% over the past week.

Analysis

The key signal is not the insider buy itself but the mismatch between management behavior and market positioning: when executives add on weakness after a sharp drawdown, it often marks the beginning of a valuation repair trade rather than an immediate fundamental trough. That said, this setup is usually a months-long process, not a quick mean reversion, because the next leg depends on whether the recent miss was mostly timing noise or evidence of a slower AMI conversion cycle. If backlog is genuinely deferred into 2H26, the stock can stay cheap for longer than “undervalued” screens imply.

Second-order, the weakness likely shifts bargaining power toward large municipal buyers and slows competitive pricing recovery across the meter/AMI ecosystem. Competitors with cleaner near-term ship visibility and less exposure to project timing should gain relative share in investor perception, even if underlying demand is intact. The market is likely discounting a lower growth trajectory, so any additional evidence of delayed deployments would hit the multiple harder than another modest EPS miss.

The contrarian view is that this may be a quality cyclical rerating rather than a broken story: if the core demand pipeline is intact, the selloff has probably compressed expectations too far and creates upside once shipment timing normalizes. The risk is that investors anchor on insider buying as a floor, but insider support does not arrest de-rating when margins and revenue visibility deteriorate. Near-term catalysts are the next quarter’s backlog conversion, management commentary on project timing, and whether buy-side models cut estimates again over the next 2-6 weeks.

Key Decisions for Investors

• Initiate a tactical long in BMI only on evidence of stabilization in backlog conversion; size small and use a 1-2 quarter horizon. Risk/reward is attractive if the market has over-penalized timing issues, but downside remains if revenue deferral extends into 2H26.
• Consider a pair trade: long a high-quality industrial/sensor name with steadier visibility vs. short BMI for the next 1-3 months. The relative trade should work if the market keeps rewarding predictability over valuation in a risk-off tape.
• If already long BMI, sell covered calls into any reflex bounce over the next 2-4 weeks to monetize elevated volatility while waiting for fundamental confirmation. This limits upside but improves carry in a name likely to remain headline-driven.
• Avoid adding aggressively until management provides clearer evidence that the backlog timing issue is transitory. The bear case is not bankruptcy risk, but multiple compression if analysts keep cutting revenue and EPS estimates.